Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Cinqaero (reslizumab) for treatment of severe asthma

europeanpharmaceuticalreviewJuly 21, 2017

Tag: Cinqaero , FAD , Asthma

PharmaSources Customer Service